EcoDrugPlus

Melatonin Receptor 1a

Ensembl ID : ENSMMMG00000010545
Gene Symbol: MTNR1A
3 Cross references
205 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSMMMG00000004580
Gene Symbol: MTNR1B
3 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSMMMG00000015658
Gene Symbol: MME
3 Cross references
236 Possible Orthologues:

Membrane Primary Amine Oxidase-Like

Ensembl ID : ENSMMMG00000004888
Gene Symbol: LOC107150547
2 Cross references
319 Possible Orthologues:

Membrane Primary Amine Oxidase-Like

Ensembl ID : ENSMMMG00000004904
Gene Symbol: LOC107150550
2 Cross references
319 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSMMMG00000020081
Gene Symbol: METAP2
3 Cross references
214 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSMMMG00000020725
Gene Symbol: MAPT
2 Cross references
255 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSMMMG00000000535
Gene Symbol: MAPK1
3 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSMMMG00000003638
Gene Symbol: MAPK10
3 Cross references
147 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSMMMG00000009926
Gene Symbol: LOC107134485
2 Cross references
199 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSMMMG00000024347
Gene Symbol: MAPK14
3 Cross references
276 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSMMMG00000023724
Gene Symbol: MAPK3
3 Cross references
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).